Tata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...

Wildlife thrives in Chernobyl's exclusion zone. Grey wolves there show remarkable genetic changes. These wolves have developed resistance t...

Bayer, through its subsidiary Viralgen, is advancing cell and gene therapies (CGT) to cure diseases like Parkinson's, oncology, cardiovascu...

As per Bharat Biotech, the facility will tackle scientific challenges such as targeted gene expression, immune system modulation, and long-...

Bharat Biotech has invested $75 million in its first cell and gene therapy facility in Telangana, India, aiming to launch new therapies in ...

East Ocyon Bio aims to reshape India’s role in the global biotech landscape, creating an ecosystem where pioneering therapies are developed...

The US Food and Drug Administration (FDA) has approved two gene therapies for sickle cell disease, including the first treatment in the US ...

Laurus Labs is set to increase its stake in Immunoadoptive Cell Therapy (lmmunoACT) by 7.24% for $10.6m, taking its total stake in the comp...

Immuneel Therapeutics is working on developing its own pipeline of chimeric antigen receptor T-cell (CAR-T) therapies and other cellular im...

In an interview to ET, Jonathan Hunt, CEO and MD of Syngene said the company has spare capacity and is also investing on expansion of micro...

One of the biggest challenges in biology and bioinformatics is processing and analysing huge amounts of data, and the new applications will...

The order in which our genes are activated after fertilisation has remained one of the last uncharted territories of human development.

Apollo Hospitals will import a proton beam machine from Belgium-based healthcare equipment maker IBA for particle beam therapy in cancer tr...

In what is seen as a boost to the stem cell research in the country, India would soon get to host human clinical trials for therapies using...

In an e-mail interview with ET, Henri A Termeer, Chairman, President & CEO of Genzyme Corporation discusses the latest trends in the area o...

The day may not be too far when India may become a global hub for cure to deadly diseases such as cancer, neurology and cardiac problems. B...

An Indian researcher at the Centre for Cellular and Molecular Biology (CCMB) in Hyderabad believes that he and members of his former group ...